Waitlist Mortality and Posttransplant Outcomes in African Americans with Autoimmune Liver Diseases.


Journal

Journal of transplantation
ISSN: 2090-0007
Titre abrégé: J Transplant
Pays: United States
ID NLM: 101519118

Informations de publication

Date de publication:
2021
Historique:
received: 22 10 2020
revised: 11 02 2021
accepted: 25 07 2021
entrez: 16 8 2021
pubmed: 17 8 2021
medline: 17 8 2021
Statut: epublish

Résumé

Liver transplantation is indicated in end-stage liver disease due to autoimmune diseases. The liver allocation system can be affected by disparities such as decreased liver transplant referrals for racial minorities, especially African Americans that negatively impact the pre- and posttransplant outcomes. To determine differences in waitlist survival and posttransplant graft survival rates between African American and Caucasian patients with autoimmune liver diseases. African Americans were more likely to be removed from the waitlist for death or clinical deterioration (subdistribution hazard ratio (SHR) 1.26, 95% CI 1-1.58, Despite the current efforts to reduce racial disparities, we found that African Americans are more likely to die on the waitlist for liver transplant and are less likely to be transplanted, with no differences in graft survival rates. The persistence of healthcare disparities continues to negatively impact African Americans.

Sections du résumé

BACKGROUND BACKGROUND
Liver transplantation is indicated in end-stage liver disease due to autoimmune diseases. The liver allocation system can be affected by disparities such as decreased liver transplant referrals for racial minorities, especially African Americans that negatively impact the pre- and posttransplant outcomes.
AIM OBJECTIVE
To determine differences in waitlist survival and posttransplant graft survival rates between African American and Caucasian patients with autoimmune liver diseases.
RESULTS RESULTS
African Americans were more likely to be removed from the waitlist for death or clinical deterioration (subdistribution hazard ratio (SHR) 1.26, 95% CI 1-1.58,
CONCLUSIONS CONCLUSIONS
Despite the current efforts to reduce racial disparities, we found that African Americans are more likely to die on the waitlist for liver transplant and are less likely to be transplanted, with no differences in graft survival rates. The persistence of healthcare disparities continues to negatively impact African Americans.

Identifiants

pubmed: 34394979
doi: 10.1155/2021/6692049
pmc: PMC8357471
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

6692049

Informations de copyright

Copyright © 2021 John Paul Nsubuga et al.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest or sources of funding to declare.

Références

Hepatology. 2001 Nov;34(5):889-95
pubmed: 11679959
Liver Transpl Surg. 1998 Nov;4(6):499-505
pubmed: 9791161
Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):765-82
pubmed: 22117641
Mod Pathol. 2007 Feb;20 Suppl 1:S15-30
pubmed: 17486048
Liver Transpl. 2015 Jul;21(7):904-13
pubmed: 25865817
Ther Adv Chronic Dis. 2016 Jan;7(1):68-85
pubmed: 26770670
J Hepatol. 2014 Jan;60(1):210-23
pubmed: 24084655
J Clin Gastroenterol. 2020 Aug;54(7):648-654
pubmed: 31651572
Transplantation. 2019 Jul;103(7):1425-1432
pubmed: 30418427
J Transplant. 2012;2012:870659
pubmed: 23304446
Transplantation. 2002 Oct 15;74(7):1007-12
pubmed: 12394846
Am J Transplant. 2009 Sep;9(9):2113-8
pubmed: 19624565
Clin Transplant. 2014 Jul;28(7):755-61
pubmed: 24750171
Liver Transpl. 2010 Sep;16(9):1033-40
pubmed: 20818740
Clin Gastroenterol Hepatol. 2019 Jul;17(8):1616-1624.e2
pubmed: 30471454
N Engl J Med. 2006 Jan 5;354(1):54-66
pubmed: 16394302
Liver Int. 2020 Feb;40(2):437-446
pubmed: 31505081
J Clin Gastroenterol. 2020 Mar;54(3):263-270
pubmed: 31169758
Liver Transpl. 2013 Oct;19(10):1065-77
pubmed: 23873751
Clin Gastroenterol Hepatol. 2020 May;18(5):1170-1178.e6
pubmed: 31606455
Am J Gastroenterol. 2008 Apr;103(4):901-10
pubmed: 18371131
Am J Hum Genet. 2016 Jan 7;98(1):165-84
pubmed: 26748518
Transplant Proc. 1997 Dec;29(8):3726-8
pubmed: 9414904
JAMA. 2000 May 10;283(18):2445-50
pubmed: 10815094
Clin Gastroenterol Hepatol. 2019 Feb;17(3):551-559.e1
pubmed: 29859983
Liver Transpl. 2004 Jul;10(7):834-41
pubmed: 15237365

Auteurs

John Paul Nsubuga (JP)

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Daniela Goyes (D)

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Hirsh D Trivedi (HD)

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Esli Medina-Morales (E)

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Vilas Patwardhan (V)

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Alan Bonder (A)

Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Classifications MeSH